Who is sponsoring NCT04793347?

NCT04793347 is sponsored by amr bayoumi salama.

What drugs are being tested in NCT04793347?

Interventions in NCT04793347: shock master (shock waves device).

What condition does NCT04793347 study?

NCT04793347 studies Chronic Anal Fissure.

Is NCT04793347 still recruiting?

NCT04793347 is currently status unknown. Last updated 11 March 2021.

Last reviewed 2021-03-11 · How we verify

NCT04793347

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Shock Waves Therapy on Chronic Anal Fissure

Status unknown NA Last updated 11 March 2021

What this trial tests

NA trial testing shock master (shock waves device) in Chronic Anal Fissure in 20 participants. Status unknown.

Timeline

10 March 2021

Primary endpoint
30 April 2021

30 May 2021

Quick facts

Lead sponsor	amr bayoumi salama
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	20
Start date	10 March 2021
Primary completion	30 April 2021
Estimated completion	30 May 2021
Sites	1 location across Egypt

Drugs / interventions tested

shock master (shock waves device)

Conditions studied

Chronic Anal Fissure — all drugs for Chronic Anal Fissure →

Sponsor

amr bayoumi salama

Who can join

Adults 18 to 50, any sex, with Chronic Anal Fissure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

the study conducted to assess if there is an effect of Extracorporeal Shock Wave Treatment on anal fissure

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Anal Fissure

Currently open trials in the same condition.

NCT07268261 — Combined Method of Surgical Treatment of Anal Fissure · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04793347 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by amr bayoumi salama
Last refreshed: 11 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04793347.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing